Heart Beat: June 2018

0
Its both a tragedy and an irony when a powerful chemotherapy agent cures a woman of breast cancer, only to leave her with heart failure or cardiomyopathy. It is not uncommon. Some of the most effective chemotherapy drugs used in the fight against breast cancer are known to be toxic to the heart. These include the anthracyclines, such as doxorubicin (Adriamycin), and the monoclonal antibody trastuzumab (Herceptin). The risk is great enough to cause some oncologists to discontinue using these effective drugs.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access